Cancer registration in Slovenia has a long tradition. The Cancer Registry of the Republic of Slovenia was founded at the Institute of Oncology Ljubljana in 1950it is one of the oldest population-based cancer registries in Europe. Cancer incidence, prevalence and survival data are collected and published for more than 60 years and traditionally distributed to users in the form of printed annual reports and technical papers. Last year, a novelty was introduced in the field of data dissemination and presentation: an interactive website called SLORA was activated on the web address www.slora.si. The principle objective of the SLORA interactive web portal is to provide public health and clinical professionals, health care organizations, civil so...
Cancer patients suffering from bone metastases are at increased risk for skeletal complications, whi...
PET/CT using 18F-fluorodeoxyglucose (FDG-PET/CT) is performed at the Institute of Oncology Ljubljana...
We retrospectively analyzed the data from 55 patients treated for noninflammatory locally advanced b...
Cancer registration in Slovenia has a long tradition. The Cancer Registry of the Republic of Sloveni...
Malignant tumors of major salivary glands are a rare and heterogeneous group of diseases. On average...
Gastrointestinalni tumorji (GIST) so redke neoplazme mezenhimskega izvora, ki na celični površini iz...
Hormonsko zdravljenje s kastracijo je v začetku navadno učinkovito pri večini bolnikov z razsejanim ...
Neoplastic meningitis is a serious complication of malignant disease. In spite of low incidence, its...
The Slovenian national cervical cancer screening program ZORAwas established in 2003.. The Screening...
Nasopharyngeal carcinoma (NPC) is a rare disease in the Slovenian population. Treatment depends also...
Prognoza pri karcinomu dojk je v veliki meri odvisna od bioloških lastnosti karcinoma. Kozmetične sp...
Circulating tumor cells (CTCs) are epithelial tumor cells detected in the peripheral blood of patien...
Maligni tumorji velikih žlez slinavk so redka in raznolika skupina bolezni. V Sloveniji za to obliko...
Circulating tumor cells (CTCs) are epithelial tumor cells detected in the peripheral blood of patien...
Neoplastični meningitis je resen zaplet maligne bolezni. Kljub majhni incidenci njegova pogostost na...
Cancer patients suffering from bone metastases are at increased risk for skeletal complications, whi...
PET/CT using 18F-fluorodeoxyglucose (FDG-PET/CT) is performed at the Institute of Oncology Ljubljana...
We retrospectively analyzed the data from 55 patients treated for noninflammatory locally advanced b...
Cancer registration in Slovenia has a long tradition. The Cancer Registry of the Republic of Sloveni...
Malignant tumors of major salivary glands are a rare and heterogeneous group of diseases. On average...
Gastrointestinalni tumorji (GIST) so redke neoplazme mezenhimskega izvora, ki na celični površini iz...
Hormonsko zdravljenje s kastracijo je v začetku navadno učinkovito pri večini bolnikov z razsejanim ...
Neoplastic meningitis is a serious complication of malignant disease. In spite of low incidence, its...
The Slovenian national cervical cancer screening program ZORAwas established in 2003.. The Screening...
Nasopharyngeal carcinoma (NPC) is a rare disease in the Slovenian population. Treatment depends also...
Prognoza pri karcinomu dojk je v veliki meri odvisna od bioloških lastnosti karcinoma. Kozmetične sp...
Circulating tumor cells (CTCs) are epithelial tumor cells detected in the peripheral blood of patien...
Maligni tumorji velikih žlez slinavk so redka in raznolika skupina bolezni. V Sloveniji za to obliko...
Circulating tumor cells (CTCs) are epithelial tumor cells detected in the peripheral blood of patien...
Neoplastični meningitis je resen zaplet maligne bolezni. Kljub majhni incidenci njegova pogostost na...
Cancer patients suffering from bone metastases are at increased risk for skeletal complications, whi...
PET/CT using 18F-fluorodeoxyglucose (FDG-PET/CT) is performed at the Institute of Oncology Ljubljana...
We retrospectively analyzed the data from 55 patients treated for noninflammatory locally advanced b...